Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy
NCT02438709
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Primary Hypertrophic Osteoarthropathy
Interventions
DRUG:
COX-2 inhibitor
Sponsor
Peking Union Medical College Hospital